1. Home
  2. PDFS vs SUPN Comparison

PDFS vs SUPN Comparison

Compare PDFS & SUPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PDF Solutions Inc.

PDFS

PDF Solutions Inc.

SELL

Current Price

$54.04

Market Cap

2.1B

Sector

Technology

ML Signal

SELL

Logo Supernus Pharmaceuticals Inc.

SUPN

Supernus Pharmaceuticals Inc.

SELL

Current Price

$42.34

Market Cap

2.5B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
PDFS
SUPN
Founded
1992
2005
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
2.5B
IPO Year
2000
2010

Fundamental Metrics

Financial Performance
Metric
PDFS
SUPN
Price
$54.04
$42.34
Analyst Decision
Buy
Buy
Analyst Count
8
4
Target Price
$61.50
★ $61.75
AVG Volume (30 Days)
526.4K
★ 583.8K
Earning Date
11-05-2026
11-03-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ 0.22
N/A
Revenue
N/A
★ $392,755,000.00
Revenue This Year
$20.46
$23.21
Revenue Next Year
$20.66
$54.85
P/E Ratio
$247.43
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$23.55
$40.51
52 Week High
$71.69
$59.68

Technical Indicators

Market Signals
Indicator
PDFS
SUPN
Relative Strength Index (RSI) 60.96 44.69
Support Level $49.15 $40.51
Resistance Level $56.46 $52.33
Average True Range (ATR) 1.95 1.35
MACD 0.40 0.05
Stochastic Oscillator 72.14 32.02

Price Performance

Historical Comparison
PDFS
SUPN

About PDFS PDF Solutions Inc.

PDF Solutions Inc provides products and services designed to empower organizations across the semiconductor and electronics ecosystem to connect, collect, manage, and analyze data about design, equipment, manufacturing, and test to improve the yield and quality of their products and operational efficiency. The Company's products, services, and solutions include proprietary software, physical intellectual property (IP) for integrated circuit (IC) designs, electrical measurement hardware tools, methodologies, and professional services.

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, Osmolex ER, and others.

Share on Social Networks: